Executive Committee


David Lucchino

Co-founder, President and Chief Executive Officer of Frequency Therapeutics

Vice Chair

Charles Wilson

President and Chief Executive Officer of Unum Therapeutics


Larry Wittenberg

Senior Partner, Technology Companies & Life Sciences Group at Goodwin


John Dunlop

Vice President, Neuroscience Research at Amgen

Lizabeth Leveille

Associate Vice President and Head, Boston Innovation Hub of BD&L Merck Research Laboratories

Liz Lewis

Chief Counsel, Specialty BUs/R&D and the Head of Patient Advocacy at Takeda Oncology

Kathryn Payne

Senior Vice President of Corporate Communications and External Affairs at Orchard Therapeutics

Eric Rasmussen

Executive Director, Government Affairs & Policy at Sunovion

Bill Sibold

Executive Vice President and Head of Sanofi Genzyme

Kumar Srinivasan

Vice-President, Scientific Partnering and Alliances and Site Head, R&D Boston at AstraZeneca

Tamar Thompson

Vice President, U.S. Government Affairs, Alexion Pharmaceuticals, Inc.